Current status of photodynamic therapy in dermatology

Dermatologic Clinics

Volumn 15, Issue 3, 1997, Pages 507-519

  Bissonnette, R ^a   Lui, H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; ETIOPURPURIN; MESOTETRAPHENYLPORPHINESULFUNATE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ZINC; TALAPORFIN; UNCLASSIFIED DRUG;

ALOPECIA; BOWEN DISEASE; HUMAN; HYPERPIGMENTATION; LASER SURGERY; MYCOSIS FUNGOIDES; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; REVIEW; SCAR; SKIN CARCINOMA; SKIN METASTASIS; TREATMENT OUTCOME; YAG LASER;

EID: 0030900151     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70458-7     Document Type: Article

References (91)

1. A.L. Abramson M.J. Shikowitz V.M. Mullooly Clinical effects of photodynamic therapy on recurrent laryngeal papillomas Arch Otolaryngol Head Neck Surg 118 1992 25 29
2. B.A. Allison P.H. Pritchard J.G. Levy Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative Br J Cancer 69 1994 833 839
3. R. Ammann T. Hunziker L.R. Braathen Topical photodynamic therapy in verrucae Dermatology 191 1995 346 347
4. M.W. Berns M. Rettenmaier J. McCullough Response of psoriasis to red laser light (630 nm) following systemic injection of hematoporphyrin derivative Lasers Surg Med 4 1984 73 77
5. W.H. Boehncke K. König R. Kaufmann Photodynamic therapy in psoriasis: Suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo Arch Dermatol Res 286 1994 300 303
6. W.H. Boehncke W. Sterry R. Kaufmann Treatment of psoriasis by topical photodynamic therapy with polychromatic light Lancet 343 1994 801
7. R.B. Buchanan J.A.S. Carruth A.L. McKenzie Photodynamic therapy in the treatment of malignant tumours of the skin and head and skin Eur J Surg Oncol 15 1989 400 406
8. F. Cairnduff M.R. Stringer E.J. Hudson Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer Br J Cancer 69 1994 605 608
9. P.G. Calzavara-Pinton Repetitive photodynamic therapy with topical δ-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumors J Photochem Photobiol B 29 1995 53 57
10. P. Charlesworth T.G. Truscott The use of 5-amino-levulinic acid (ALA) in photodynamic therapy (PDT) J Photochem Photobiol B 18 1993 99 100
11. M.D. Daniell J.S. Hill A history of photodynamic therapy Aust NZ J Surg 61 1991 340 348
12. D.X.G. Divaris J.C. Kennedy R.H. Pottier Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence Am J Pathol 136 1990 891 897
13. T.J. Dougherty Photodynamic therapy Photochem Photobiol 58 1993 895 900
14. T.J. Dougherty Photoradiation therapy for cutaneous and subcutaneous malignancies J Invest Dermatol 77 1981 122 124
15. T.J. Dougherty Studies on the structure of porphyrins contained in Photofrin™ II Photochem Photobiol 46 1987 569 573
16. T.J. Dougherty J.E. Kaufmann A. Goldfarb Photoradiation therapy for the treatment of malignant tumors Cancer Res 38 1978 2628 2635
17. T.J. Dougherty S.L. Marcus Photodynamic therapy Eur J Cancer 28A 1992 1734 1742
18. T.J. Dougherty A.R. Oseroff B.D. Wilson An update of Photofrin®—Photodynamic therapy (PDT) for cutaneous tumors Lasers Surg Med Suppl 8 1996 26
19. L. Emtestam L. Berglund B. Angelin Tin-protoporphyrin and long wave length ultraviolet light in treatment of psoriasis Lancet I 1989 1231 1233
20. I. Favilla M.L. Favilla A.D. Gosbell Photodynamic therapy: A 5-year study of its effectiveness in the treatment of posterior uveal melanoma, and evaluation of haematoporphyrin uptake and photocytotoxicity of melanoma cells in tissue culture Melanoma Res 5 1995 355 364
21. M.K. Fehr C.F. Chapman T. Krasieva Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid Am J Obstet Gynecol 174 1996 951 957
22. S. Fijan H. Hönigsmann B. Ortel Photodynamic therapy of epithelial skin tumors using delta-aminolaevulinic acid and desferrioxamine Br J Dermatol 133 1995 282 288
23. A.M.R. Fisher A.L. Murphree C.J. Gomer Clinical and preclinical photodynamic therapy Lasers Surg Med 17 1995 2 31
24. C.J. Gomer N.J. Razum Acute skin response in albino mice following porphyrin photosensitization under oxic and anoxic conditions Photochem Photobiol 40 1984 435 439
25. L. Gossner R. Stroka E.G. Hahn Photodynamic therapy: Successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid Gastrointest Endosc 41 1995 55 58
26. W.E. Grant C. Hopper A.J. MacRobert Photodynamic therapy of oral cancer: Photosensitisation with systemic aminolevulinic acid Lancet 342 1993 147 148
27. R.C. Grekin T. Berger M. Whitfield Tin ethyl etiopurpurin (SnET2): Phase I/II clinical results for the treatment of AIDS-related cutaneous Kaposi's sarcomas at the University of California, San Francisco Lasers Surg Med Suppl 7 1995 44
28. D.J. Gross M. Waner R.H. Schosser Squamous cell carcinoma of the lower lip involving a large cutaneous surface Arch Dermatol 126 1990 1148 1150
29. M. Grossmann J. Wimberly P. Dwyer PDT for hirsutism Lasers Surg Med Suppl 7 1995 44
30. E.F. Gudgin Dickson R.H. Pottier On the role of protoporphyrin IX photoproducts in photodynamic therapy J Photochem Photobiol B 29 1995 91 93
31. B.W. Henderson T.J. Dougherty How does photodynamic therapy work? Photochem Photobiol 55 1992 145 157
32. L. Hruza H. Lui G. Hruza Response of psoriasis to photodynamic therapy using benzoporphyrin derivative monoacid ring A Lasers Surg Med Suppl 7 1995 43
33. C.M. Jones T. Mang M. Cooper Photodynamic therapy in the treatment of Bowen's disease J Am Acad Dermatol 27 1992 979 982
34. S. Karrer R.M. Szeimies U. Hohenleutner Unilateral localized basaliomatosis: Treatment with topical photodynamic therapy after application of 5-aminolevulinic acid Dermatology 190 1995 218 222
35. G.S. Keller N.J. Razum D.R. Doiron Photodynamic therapy for nonmelanoma skin cancer Facial Plast Surg 6 1989 58 62
36. J.C. Kennedy R.H. Pottier Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy J Photochem Photobiol B 14 1992 275 292
37. J.C. Kennedy R.H. Pottier D.C. Pross Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience J Photochem Photobiol B 6 1990 143 148
38. M. Kongshaug J. Moan S.B. Brown The distribution of porphyrin with different tumor localizing ability among human plasma proteins Br J Cancer 59 1989 184 188
39. M. Korbelik G. Krosl Accumulation of benzoporphyrin derivative in malignant and host cell populations of the murine RIF tumor Cancer Lett 97 1995 249 254
40. M. Korbelik G. Krosl Cellular levels of photosensitizers in tumors: The role of proximity to the blood supply Br J Cancer 70 1994 604 610
41. M. Korbelik P. Krosl L. Olive Distribution of Photofrin between tumour cells and tumour associated macrophages Br J Cancer 64 1991 508 512
42. J.G. Levy Photosensitizers in photodynamic therapy Semin Oncol 21 1994 4 10
43. C.S. Loh A.J. MacRobert J. Bedwell Oral versus intravenous administration of ALA for photodynamic therapy Br J Cancer 68 1993 41 51
44. H. Lui R.R. Anderson Photodynamic therapy in dermatology: Recent developments Dermatol Clin 11 1993 1 13
45. Lui H, Hruza L, McLean D, et al: Photodynamic therapy of malignant skin tumors with BPD-verteporfin. A photosensitizer that does not induce prolonged cutaneous photosensitivity. Submitted for publication
46. H. Lui S. Salasche N. Kollias Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: A clinical and histologic study Arch Dermatol 131 1995 737 738
47. H. Lui H. Zeng D.I. McLean In vivo fluorescence spectroscopy monitoring of BPD verteporfin concentration changes in skin tissue during photodynamic therapy of skin cancer J Dermatol Sci 12 1996 87
48. Y. Luo C.K. Chang D. Kessel Rapid initiation of apoptosis by photodynamic therapy Photochem Photobiol 63 1996 528 534
49. Z. Malik H. Lugaci Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins Br J Cancer 56 1987 589 595
50. T.S. Mang T.J. Dougherty W.R. Potter Photobleaching of porphyrins used in photodynamic therapy and implications for therapy Photochem Photobiol 45 1987 501 506
51. S.L. Marcus A.L. Golub D.G. Shulman Photodynamic therapy using 5-aminolevulinic acid-induced photosensitization: Current clinical status. In 5th International Photodynamic Association Biennial Meeting Proc SPIE 2371 1995 24 30
52. A. Martin W.D. Tope J.M. Grevelink Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: Implications for photodynamic treatment Arch Dermatol Res 287 1995 665 674
53. J.S. McCaughan Photodynamic therapy of skin and esophageal cancers Cancer Invest 8 1990 407 416
54. P. Mlkvy H. Messmann J. Regula Sensitization and photodynamic therapy (PDT) of gastrointestinal tumors with 5-aminolaevulinic acid (ALA) induced protoporphyrin IX (PPIX). A pilot study Neoplasma 42 1995 109 113
55. G. Monfrecola F. D'Anna M. Delfino Topical hematoporphyrin plus UVA for treatment of alopecia areata Photodermatology 4 1987 305 306
56. J.G. Morelli O.T. Tan J. Garden Tunable dye laser (577 nm) treatment of port wine stains Lasers Surg Med 6 1986 94 99
57. J.S. Nelson E.W.B. Jeffes J.L. Weinstein Topical 5-aminolevulinic acid for the photodynamic therapy of psoriasis and actinic keratoses Lasers Surg Med Suppl 7 1995 43
58. J.S. Nelson L.H. Liaw A. Orenstein Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, phthalocyanine J Natl Cancer Inst 80 1988 1599 1605
59. B. Ortel A. Tanew H.I. Honigsmann Lethal photosensitization by endogenous porphyrins of PAM cells—Modification by desferrioxamine J Photochem Photobiol B 17 1993 273 278
60. A.R. Oseroff S.D. Shanler D.A. Buscaglia PDT with topical δ-aminolevulinic acid (ALA) for the treatment of patch and plaque stage cutaneous T-cell lymphoma Lasers Surg Med Suppl 7 1995 39
61. Q. Peng T. Warloe J. Moan Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma Photochem Photobiol 62 1995 906 913
62. N.J. Petrelli J.A. Cebollero M. Rodriguez-Bigas Photodynamic therapy in the management of neoplasms of the perianal skin Arch Surg 127 1992 1436 1438
63. V.H. Pres H. Meffert N. Sönnichsen Topically applied hematoporphyrin derivative plus visible light for photodynamic treatment of palmoplantar psoriasis Dermatol Monschr 175 1989 745 750
64. N.J. Razum A.B. Snyder D.R. Doiron SnET2: clinical update. In Optical methods for tumor treatment and detection: Mechanism and techniques in photodynamic therapy Proc SPIE 2675 1996 43 46
65. J. Regula A.J. MacRobert A. Gorchein Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumors using 5 aminolaevulinic acid induced protoporphyrin IX—A pilot study Gut 36 1995 67 75
66. H.B. Ris H.J. Altermatt R. Inderbitzi Photodynamic therapy with chlorins for diffuse malignant mesothelioma: Initial clinical results Br J Cancer 64 1991 1116 1120
67. K. Rittenhouse-Diakun H. Van Leengoed J. Morgan The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor δ-aminolevulinic acid (ALA) Photochem Photobiol 61 1995 523 528
68. O. Santoro G. Bandieramonte E. Melloni Photodynamic therapy by topical mesotetraphenylporphinesulfonate tetrasodium salt administration in superficial basal cell carcinomas Cancer Res 50 1990 4501 4503
69. U. Schmidt-Erfurth W. Bauman E. Gragoudas Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin Ophthalmology 101 1994 89 99
70. N. Schoenfeld R. Mamet Y. Nordenberg Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: Characterization of photodynamic inactivation Int J Cancer 56 1994 106 112
71. V.G. Schweitzer D. Visscher Photodynamic therapy for treatment of AIDS-related Kaposi sarcoma Otolaryngol Head Neck Surg 102 1990 639 649
72. S.D. Shanler W. Wan J.E. Whitaker Topical δ-aminolevulinic acid for photodynamic therapy of cutaneous carcinomas and cutaneous T cell lymphoma J Invest Dermatol 101 1993 406
73. C.A. Sommer H. van Leengoed C.M. Conti Photodynamic therapy (PDT) for cutaneous carcinomas using the second generation photosensitizer tin ethyl ethiopurpurin (SnET2) Lasers Surg Med Suppl 7 1995 45
74. P.W. Sperduto T.F. De Laney G. Thomas Photodynamic therapy for chest wall recurrence in breast cancer Int J Radiat Oncol Biol Phys 21 1991 441 446
75. I.M. Stender H.C. Wulf Photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic cheilitis Br J Dermatol 135 1996 454 456
76. K. Svanberg T. Andersson D. Killander Photodynamic therapy of nonmelanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation Br J Dermatol 130 1994 743 751
77. R.M. Szeimies C. Abels C. Fritsch Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo J Invest Dermatol 105 1995 672 677
78. R.M. Szeimies T. Sassy M. Landthaler Penetration potency of topical applied δ-aminolevulinic acid for photodynamic therapy of basal cell carcinoma Photochem Photobiol 59 1994 73 76
79. W.D. Tope N. Kollias A. Martin Oral delta-aminolevulinic acid induces full thickness protoporphyrin IX fluorescence in basal cell carcinoma Lasers Surg Med Suppl 7 1995 40
80. D.T. Tse R.C. Kersten R.L. Anderson Hematoporphyrin derivative photoradiation therapy in managing nevoid basal cell carcinoma syndrome Arch Ophthalmol 102 1984 990 994
81. I.P.J. van Geel H. Oppelaar J.P.A. Marijnissen Influence of fractionation and fluence rate in photodynamic therapy with photofrin or mTHPC Radiat Res 145 1996 602 609
82. S.M. Waldow R.V. Lobraico I.K. Kohler Photodynamic therapy for treatment of malignant cutaneous lesions Lasers Surg Med 7 1987 451 456
83. T. Warloe Q. Peng J. Heyerdahl Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma. In 5th International Photodynamic Association Biennial Meeting Proc SPIE 2371 1995 226 235
84. G.D. Weinstein J.L. McCullough J.S. Nelson Low dose Photofrin II photodynamic therapy of psoriasis Clin Res 39 1991 509A
85. B.L. Wenig D.M. Kurtzman L.I. Grossweiner Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck Arch Otolaryngol Head Neck Surg 116 1990 1267 1271
86. B.D. Wilson Z. Bernstein C. Sommer Photodynamic therapy for the treatment of Kaposi's sarcoma: A comparison study utilizing Photofrin and tin ethyl-ethiopurpurin Lasers Surg Med Suppl 7 1995 45
87. B.D. Wilson T. Mang Photodynamic therapy for cutaneous malignancies Clin Dermatol 13 1995 91 96
88. B.D. Wilson T.S. Mang H. Stoll Photodynamic therapy for the treatment of basal cell carcinoma Arch Dermatol 128 1992 1597 1601
89. P. Wolf R. Fink-Puches L. Cerroni Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid J Am Acad Dermatol 31 1994 678 680
90. P. Wolf E. Rieger H. Kerl Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid J Am Acad Dermatol 28 1993 17 21
91. R.S. Wooten K.C. Smith D.A. Ahlquist Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative Lasers Surg Med 8 1988 294 300